NCT07089524 A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis
| NCT ID | NCT07089524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-09-11 |
| Primary Completion | 2025-09-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2024-09-11 with a primary completion date of 2025-09-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim of this study is to predict the prognostic values of Neutrophil/ Lymphocyte ratio and Lactate/Albumin ratio in the outcome of patients with sepsis and septic shock with lower respiratory tract infection, also to compare between them regarding sensitivity and specificity.
Eligibility Criteria
Inclusion Criteria: * Adults with lower respiratory tract infection * Confirmed septic patients (under the third international consensus definitions of sepsis and septic shock), * Admitted to intensive care unit. * Age (18-80) years. * Both genders. Exclusion Criteria: * Age: \< 18 years old, \> 80 years old * Patient refusal. * Pregnancy. * Malignancy. * Pathology that could affect serum albumin concentrations prior to ICU admission as Malnutrition * Nephrotic syndrome * Liver Cirrhosis * Intestinal resection surgeries
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07089524 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07089524 currently recruiting?
Yes, NCT07089524 is actively recruiting participants. Contact the research team at ahmed_gamal@med.asu.edu.eg for enrollment information.
Where is the NCT07089524 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07089524 clinical trial?
NCT07089524 is sponsored by Ain Shams University. The trial plans to enroll 160 participants.